Saint Vincent and the Grenadines vs Tajikistan: Hepatitis B surface antigen (HBsAg) prevalence
Saint Vincent and the Grenadines
0.2%
in 2024
Tajikistan
0.2%
in 2024
Saint Vincent and the Grenadines rank
82nd
Tajikistan rank
82nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Saint Vincent and the Grenadines
- Tajikistan
How they compare
Saint Vincent and the Grenadines currently reports 0.2% against 0.2% in Tajikistan, a difference of 0.0%.
Across all 10 years both countries report, Tajikistan has been ahead every year.
Saint Vincent and the Grenadines ranks 82nd and Tajikistan ranks 82nd of 194 countries.
Tajikistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Saint Vincent and the Grenadines | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.0% | Tajikistan |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Saint Vincent and the Grenadines or Tajikistan?
- Saint Vincent and the Grenadines, at 0.2% against 0.2% in Tajikistan as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Saint Vincent and the Grenadines and Tajikistan?
- 0.0%, with Saint Vincent and the Grenadines ahead.
- How many years of comparable data are there for Saint Vincent and the Grenadines and Tajikistan?
- 10 years are reported by both, from 2015 to 2024.
- How do Saint Vincent and the Grenadines and Tajikistan rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Saint Vincent and the Grenadines ranks 82nd and Tajikistan ranks 82nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.